{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:14:53Z","timestamp":1793052893055,"version":"4.5.0"},"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2009,9,3]],"date-time":"2009-09-03T00:00:00Z","timestamp":1251936000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0006896","type":"journal-article","created":{"date-parts":[[2009,9,2]],"date-time":"2009-09-02T22:43:54Z","timestamp":1251931434000},"page":"e6896","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":194,"title":["Hypoxia and TGF-\u03b2 Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone Microenvironment"],"prefix":"10.1371","volume":"4","author":[{"given":"Lauren K.","family":"Dunn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid S.","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierrick G. J.","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Ryan","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly W.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Niewolna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang Hong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Chirgwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa A.","family":"Guise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,9,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis.","volume":"350","author":"GD Roodman","year":"2004","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities.","volume":"2","author":"GR Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","article-title":"TGFbeta in Cancer.","volume":"134","author":"J Massague","year":"2008","journal-title":"Cell"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1101\/gad.1350705","article-title":"Smad transcription factors.","volume":"19","author":"J Massague","year":"2005","journal-title":"Genes Dev"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1056\/NEJMra0805239","article-title":"Molecular basis of metastasis.","volume":"359","author":"AC Chiang","year":"2008","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI3523","article-title":"TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development.","volume":"103","author":"JJ Yin","year":"1999","journal-title":"J Clin Invest"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"24571","DOI":"10.1074\/jbc.M202561200","article-title":"Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways.","volume":"277","author":"SM Kakonen","year":"2002","journal-title":"J Biol Chem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","article-title":"A multigenic program mediating breast cancer metastasis to bone.","volume":"3","author":"Y Kang","year":"2003","journal-title":"Cancer Cell"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1158\/0008-5472.CAN-05-2630","article-title":"Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.","volume":"65","author":"MS Bendre","year":"2005","journal-title":"Cancer Res"},{"key":"ref10","first-page":"5571","article-title":"Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo.","volume":"62","author":"MS Bendre","year":"2002","journal-title":"Cancer Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1158\/0008-5472.CAN-05-3560","article-title":"The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.","volume":"66","author":"M Deckers","year":"2006","journal-title":"Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"13909","DOI":"10.1073\/pnas.0506517102","article-title":"Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway.","volume":"102","author":"Y Kang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1158\/0008-5472.CAN-06-3950","article-title":"Stable Overexpression of Smad7 in Human Melanoma Cells Impairs Bone Metastasis.","volume":"67","author":"D Javelaud","year":"2007","journal-title":"Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1158\/1078-0432.CCR-06-0162","article-title":"Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-beta type I receptor kinase in vivo.","volume":"12","author":"R Ge","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"6714","DOI":"10.1158\/0008-5472.CAN-05-3565","article-title":"Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-beta type I receptor kinase inhibitor.","volume":"66","author":"A Bandyopadhyay","year":"2006","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1172\/JCI200215333","article-title":"Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects.","volume":"109","author":"YA Yang","year":"2002","journal-title":"J Clin Invest"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1172\/JCI0215234","article-title":"Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.","volume":"109","author":"RS Muraoka","year":"2002","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"7540","DOI":"10.1158\/1078-0432.CCR-04-0632","article-title":"Transforming growth factor beta receptor I kinase inhibitor down-regulates cytokine secretion and multiple myeloma cell growth in the bone marrow microenvironment.","volume":"10","author":"T Hayashi","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00774-007-0765-9","article-title":"Oxygen tension is an important mediator of the transformation of osteoblasts to osteocytes.","volume":"25","author":"M Hirao","year":"2007","journal-title":"J Bone Miner Metab"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia\u2014a key regulatory factor in tumour growth.","volume":"2","author":"AL Harris","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrc1367","article-title":"Exploiting tumour hypoxia in cancer treatment.","volume":"4","author":"JM Brown","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"ref22","first-page":"5830","article-title":"Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.","volume":"59","author":"H Zhong","year":"1999","journal-title":"Cancer Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy.","volume":"3","author":"GL Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1026404227624","article-title":"Transforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells.","volume":"17","author":"WC Duivenvoorden","year":"1999","journal-title":"Clin Exp Metastasis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/CMR.0b013e3282a660ad","article-title":"Expression of collagenase-1 (MMP-1) promotes melanoma growth through the generation of active transforming growth factor-beta.","volume":"17","author":"J Iida","year":"2007","journal-title":"Melanoma Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1158\/0008-5472.CAN-06-3946","article-title":"Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.","volume":"67","author":"M Ao","year":"2007","journal-title":"Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1158\/1535-7163.MCT-08-0107","article-title":"Significant antitumor activity in vivo following treatment with the microtubule agent ENMD-1198.","volume":"7","author":"TM LaVallee","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1158\/1078-0432.CCR-07-4020","article-title":"Hypoxia-selective targeting by the bioreductive prodrug AQ4N in patients with solid tumors: results of a phase I study.","volume":"14","author":"MR Albertella","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1158\/0008-5472.CAN-07-5256","article-title":"NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis.","volume":"68","author":"SA Eccles","year":"2008","journal-title":"Cancer Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1349-7006.2006.00357.x","article-title":"Ki26894, a novel transforming growth factor-\u03b2; type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line.","volume":"98","author":"S Ehata","year":"2007","journal-title":"Cancer Science"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"7954","DOI":"10.1158\/0008-5472.CAN-04-1013","article-title":"SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.","volume":"64","author":"M Uhl","year":"2004","journal-title":"Cancer Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1535-6108(03)00077-1","article-title":"2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF.","volume":"3","author":"NJ Mabjeesh","year":"2003","journal-title":"Cancer Cell"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"8665","DOI":"10.1158\/1078-0432.CCR-04-1393","article-title":"2-methoxyestradiol inhibits hypoxia-inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma.","volume":"10","author":"JL Ricker","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1179\/016164107X229920","article-title":"The effect of 2-methoxyestradiol, a HIF-1 alpha inhibitor, in global cerebral ischemia in rats.","volume":"30","author":"D Zhou","year":"2008","journal-title":"Neurol Res"},{"key":"ref35","first-page":"3765","article-title":"Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker.","volume":"58","author":"JA Raleigh","year":"1998","journal-title":"Cancer Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/gyno.1998.5163","article-title":"Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma.","volume":"71","author":"MA Varia","year":"1998","journal-title":"Gynecol Oncol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0360-3016(02)03935-4","article-title":"HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors.","volume":"54","author":"HL Janssen","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/28867","article-title":"Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis.","volume":"394","author":"P Carmeliet","year":"1998","journal-title":"Nature"},{"key":"ref39","first-page":"4008","article-title":"Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I.","volume":"58","author":"Y Akagi","year":"1998","journal-title":"Cancer Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0014-5793(98)00359-7","article-title":"Genomic organization and promoter characterization of human CXCR4 gene.","volume":"426","author":"A Caruz","year":"1998","journal-title":"FEBS Lett"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"22473","DOI":"10.1074\/jbc.M500963200","article-title":"Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase\/PTEN\/AKT\/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha.","volume":"280","author":"RJ Phillips","year":"2005","journal-title":"J Biol Chem"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"10106","DOI":"10.1158\/0008-5472.CAN-07-1362","article-title":"2-Methoxyestradiol suppresses osteolytic breast cancer tumor progression in vivo.","volume":"67","author":"M Cicek","year":"2007","journal-title":"Cancer Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1158\/1078-0432.CCR-08-1599","article-title":"Phase I trial of 2-methoxyestradiol NanoCrystal dispersion in advanced solid malignancies.","volume":"15","author":"AJ Tevaarwerk","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/sj.bjc.6604382","article-title":"Risks and benefits of bisphosphonates.","volume":"98","author":"RE Coleman","year":"2008","journal-title":"Br J Cancer"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.ctrv.2008.03.008","article-title":"Emerging role of bisphosphonates in the clinic\u2014antitumor activity and prevention of metastasis to bone.","volume":"34","author":"A Lipton","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1158\/0008-5472.CAN-06-2355","article-title":"Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.","volume":"67","author":"T Hiraga","year":"2007","journal-title":"Cancer Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1189\/jlb.0806517","article-title":"Mechanisms underlying TGF-beta1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis.","volume":"81","author":"SH Jeon","year":"2007","journal-title":"J Leukoc Biol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"38527","DOI":"10.1074\/jbc.M104536200","article-title":"Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression.","volume":"276","author":"T Sanchez-Elsner","year":"2001","journal-title":"J Biol Chem"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1158\/0008-5472.CAN-06-2701","article-title":"Hypoxia-inducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression.","volume":"67","author":"D Liao","year":"2007","journal-title":"Cancer Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10555-006-9019-x","article-title":"The pivotal role of CXCL12 (SDF-1)\/CXCR4 axis in bone metastasis.","volume":"25","author":"J Wang","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"ref51","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im2002s39","article-title":"Mouse 4T1 breast tumor model.","author":"BA Pulaski","year":"2001","journal-title":"Curr Protoc Immunol"},{"key":"ref52","article-title":"Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications.","author":"N Cabioglu","year":"2009","journal-title":"Ann Oncol"},{"key":"ref53","first-page":"761","article-title":"Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone.","volume":"21","author":"MM Richert","year":"2009","journal-title":"Oncol Rep"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0014-5793(03)00824-X","article-title":"T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer.","volume":"550","author":"H Tamamura","year":"2003","journal-title":"FEBS Lett"},{"key":"ref55","article-title":"Targeted Disruption of the CXCL12\/CXCR4 Axis Inhibits Osteolysis in a Murine Model of Myeloma-Associated Bone Loss.","author":"P Diamond","year":"2009","journal-title":"J Bone Miner Res"},{"key":"ref56","article-title":"Imaging anti-angiogenic treatment response with DCE-VCT, DCE-MRI and DWI in an animal model of breast cancer bone metastasis.","author":"T Bauerle","year":"2008","journal-title":"Eur J Radiol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1593\/neo.08220","article-title":"Bevacizumab inhibits breast cancer-induced osteolysis, surrounding soft tissue metastasis, and angiogenesis in rats as visualized by VCT and MRI.","volume":"10","author":"T Bauerle","year":"2008","journal-title":"Neoplasia"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.drup.2003.10.001","article-title":"Mechanism of action of 2-methoxyestradiol: new developments.","volume":"6","author":"SL Mooberry","year":"2003","journal-title":"Drug Resist Updat"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00001622-200311000-00004","article-title":"New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agent.","volume":"15","author":"SL Mooberry","year":"2003","journal-title":"Curr Opin Oncol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"e5275","DOI":"10.1371\/journal.pone.0005275","article-title":"Pharmacologic inhibition of the tgf-Beta type I receptor kinase has anabolic and anti-catabolic effects on bone.","volume":"4","author":"KS Mohammad","year":"2009","journal-title":"PLoS ONE"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1172\/JCI31581","article-title":"The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development.","volume":"117","author":"Y Wang","year":"2007","journal-title":"J Clin Invest"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1359\/jbmr.061207","article-title":"Enhanced bone regeneration associated with decreased apoptosis in mice with partial HIF-1alpha deficiency.","volume":"22","author":"DE Komatsu","year":"2007","journal-title":"J Bone Miner Res"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jcp.10321","article-title":"Hypoxia is a major stimulator of osteoclast formation and bone resorption.","volume":"196","author":"TR Arnett","year":"2003","journal-title":"J Cell Physiol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature07019","article-title":"Osteoclast size is controlled by Fra-2 through LIF\/LIF-receptor signalling and hypoxia.","volume":"454","author":"A Bozec","year":"2008","journal-title":"Nature"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/path.2319","article-title":"Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.","volume":"215","author":"HJ Knowles","year":"2008","journal-title":"J Pathol"},{"key":"ref66","article-title":"Acute hypoxia and osteoclast activity: a balance between enhanced resorption and increased apoptosis.","author":"HJ Knowles","year":"2009","journal-title":"J Pathol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1634\/theoncologist.11-10-1121","article-title":"Bone loss and fracture risk associated with cancer therapy.","volume":"11","author":"TA Guise","year":"2006","journal-title":"Oncologist"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1210\/en.2002-220632","article-title":"Dose-response effects of 2-methoxyestradiol on estrogen target tissues in the ovariectomized rat.","volume":"144","author":"JD Sibonga","year":"2003","journal-title":"Endocrinology"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"13491","DOI":"10.1074\/jbc.M708055200","article-title":"VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism.","volume":"283","author":"Q Zhang","year":"2008","journal-title":"J Biol Chem"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.canlet.2006.02.019","article-title":"The human Cyr61 gene is a transcriptional target of transforming growth factor beta in cancer cells.","volume":"246","author":"L Bartholin","year":"2007","journal-title":"Cancer Lett"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI118947","article-title":"Evidence for a Causal Role of Parathyroid Hormone-related Protein in the Pathogenesis of Human Breast Cancer-mediated Osteolysis.","volume":"98","author":"TA Guise","year":"1996","journal-title":"J Clin Invest"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"10954","DOI":"10.1073\/pnas.1830978100","article-title":"A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases.","volume":"100","author":"JJ Yin","year":"2003","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0006896","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T09:18:51Z","timestamp":1589015931000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0006896"}},"subtitle":[],"editor":[{"given":"Mikhail V.","family":"Blagosklonny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,9,3]]},"references-count":72,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2009,9,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0006896","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,3]]}}}